Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08  •  04:00PM ET
9.09
Dollar change
-0.13
Percentage change
-1.41
%
Index- P/E134.87 EPS (ttm)0.07 Insider Own29.84% Shs Outstand159.40M Perf Week2.71%
Market Cap1.45B Forward P/E16.60 EPS next Y0.55 Insider Trans-0.06% Shs Float111.75M Perf Month-19.34%
Enterprise Value1.58B PEG1.36 EPS next Q0.11 Inst Own85.25% Short Float16.28% Perf Quarter-17.06%
Income10.88M P/S3.48 EPS this Y1.60% Inst Trans7.74% Short Ratio8.51 Perf Half Y-22.77%
Sales415.55M P/B1.36 EPS next Y19.75% ROA0.71% Short Interest18.20M Perf YTD-14.65%
Book/sh6.68 P/C8.38 EPS next 5Y12.17% ROE1.03% 52W High15.69 -42.07% Perf Year-16.45%
Cash/sh1.08 P/FCF12.51 EPS past 3/5Y5.33% -5.78% ROIC0.80% 52W Low8.02 13.27% Perf 3Y-47.24%
Dividend Est.- EV/EBITDA15.46 Sales past 3/5Y10.42% 13.06% Gross Margin47.95% Volatility4.85% 6.13% Perf 5Y-
Dividend TTM- EV/Sales3.81 EPS Y/Y TTM134.77% Oper. Margin6.75% ATR (14)0.47 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.09 Sales Y/Y TTM11.47% Profit Margin2.62% RSI (14)43.33 Recom2.07
Dividend Gr. 3/5Y- - Current Ratio2.09 EPS Q/Q211.76% SMA203.63% Beta1.46 Target Price13.21
Payout- Debt/Eq0.29 Sales Q/Q10.33% SMA50-16.03% Rel Volume0.63 Prev Close9.22
Employees1546 LT Debt/Eq0.28 EarningsNov 06 AMC SMA200-18.87% Avg Volume2.14M Price9.09
IPODec 11, 2020 Option/ShortYes / Yes EPS/Sales Surpr.23.35% 0.09% Trades Volume1,350,222 Change-1.41%
Date Action Analyst Rating Change Price Target Change
Nov-21-25Initiated Rothschild & Co Redburn Buy $10
Nov-13-25Initiated BMO Capital Markets Market Perform $9
Sep-29-25Initiated Craig Hallum Buy $16
Jul-03-25Resumed Morgan Stanley Equal-Weight $16
May-08-25Upgrade Barclays Equal Weight → Overweight $14
Feb-27-25Initiated TD Cowen Buy $16
Sep-27-24Upgrade UBS Neutral → Buy $16
Apr-10-24Upgrade KeyBanc Capital Markets Sector Weight → Overweight $23
Apr-04-24Initiated JMP Securities Mkt Perform
Feb-26-24Initiated Leerink Partners Market Perform $19
Dec-08-25 12:20PM
09:55AM
Nov-07-25 12:13AM
Nov-06-25 06:55PM
04:15PM
10:00AM Loading…
Nov-04-25 10:00AM
08:00AM
Oct-31-25 08:00AM
Oct-30-25 04:15PM
10:00AM
Oct-20-25 08:00AM
Oct-10-25 08:00AM
Oct-02-25 09:13AM
Sep-04-25 08:00AM
Sep-02-25 04:15PM
03:28PM Loading…
Aug-07-25 03:28PM
Aug-06-25 06:00PM
04:15PM
Aug-04-25 02:00AM
Jul-31-25 04:15PM
10:00AM
Jul-30-25 10:00AM
Jul-29-25 08:25AM
Jul-18-25 08:38AM
Jul-15-25 01:56PM
Jul-11-25 12:10PM
Jul-10-25 12:39AM
Jul-09-25 04:15PM
Jul-08-25 12:05PM
08:00AM
09:10AM Loading…
Jun-28-25 09:10AM
Jun-20-25 08:25AM
May-23-25 09:17AM
May-06-25 08:31AM
03:09AM
May-05-25 07:22PM
05:45PM
04:15PM
Apr-29-25 04:15PM
10:01AM
Apr-28-25 10:00AM
Apr-21-25 08:00AM
Apr-16-25 12:10PM
Apr-15-25 12:40AM
Apr-14-25 08:15AM
08:00AM
Apr-12-25 06:45PM
02:10AM
Apr-11-25 01:15PM
10:04AM
Apr-02-25 12:49PM
Apr-01-25 08:00AM
Mar-06-25 07:58PM
Mar-05-25 04:15PM
Feb-27-25 07:59AM
02:28AM
Feb-26-25 06:45PM
04:15PM
Feb-14-25 01:12PM
Jan-29-25 04:15PM
Jan-24-25 12:48PM
Jan-15-25 07:55AM
Jan-02-25 04:15PM
Dec-06-24 10:02AM
Dec-02-24 04:15PM
Nov-13-24 09:29AM
Nov-07-24 10:38AM
02:27AM
Nov-06-24 07:05PM
04:15PM
Oct-28-24 04:15PM
Oct-16-24 04:15PM
Oct-15-24 08:05AM
Oct-09-24 04:15PM
Oct-02-24 04:15PM
Sep-27-24 07:20PM
Sep-24-24 08:00AM
Sep-18-24 08:00AM
Sep-17-24 11:02AM
Aug-28-24 07:03PM
Aug-21-24 04:15PM
Aug-15-24 04:15PM
Aug-12-24 03:57AM
Aug-07-24 12:25PM
Aug-06-24 06:25PM
04:15PM
Jul-09-24 04:45PM
Jul-02-24 04:15PM
Jun-17-24 08:00AM
May-29-24 04:15PM
May-21-24 08:00AM
May-09-24 02:45PM
May-08-24 01:16PM
05:48AM
04:13AM
May-07-24 06:40PM
05:59PM
04:15PM
May-06-24 03:19AM
Apr-16-24 08:00AM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feehery William FCHIEF EXECUTIVE OFFICERNov 11 '25Buy8.3024,096200,0002,360,769Nov 12 04:44 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSep 09 '25Sale10.9251,224559,36673,979Sep 11 04:47 PM
Pedersen Leif EOfficerSep 09 '25Proposed Sale10.9251,224559,304Sep 09 04:16 PM
Anhalt RonaChief Human Resources OfficerMay 30 '25Option Exercise0.007,14607,146Jun 02 04:58 PM
Corcoran DanielSVP and General CounselMay 30 '25Option Exercise0.0022,828020,530Jun 02 04:57 PM
WALSH MATTHEW MDirectorMay 21 '25Option Exercise0.0011,9280197,559May 22 05:07 PM
Reynders John V WDirectorMay 21 '25Option Exercise0.0010,709010,709May 22 05:05 PM
Killefer NancyDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:04 PM
Crane Rosemary ADirectorMay 21 '25Option Exercise0.0011,928029,915May 22 05:03 PM
Collins CynthiaDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:01 PM
CASHMAN JAMES E IIIChairmanMay 21 '25Option Exercise0.0011,9280468,440May 22 05:00 PM
BROSHY ERANChairmanMay 21 '25Option Exercise0.0011,928034,951May 22 04:58 PM
Aspbury RobertPRESIDENT, PREDICTIVE TECHApr 01 '25Option Exercise0.0026,6260311,936Apr 03 04:44 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '25Option Exercise0.0026,6260127,669Apr 03 04:40 PM
Gallagher John EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '25Option Exercise0.0042,486051,731Apr 03 04:36 PM
Feehery William FCHIEF EXECUTIVE OFFICERApr 01 '25Option Exercise0.00111,39302,354,346Apr 03 04:32 PM
SMITH PATRICK FOfficerApr 02 '25Proposed Sale9.7320,142195,982Apr 02 10:57 AM